JNJ Press releases
News
JNJ Press releases
Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020
Read full storyJNJ Press releases
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
Read full storyJNJ Press releases
Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation
Read full storyJNJ Press releases
Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI
Read full storyJNJ Press releases
Johnson & Johnson Innovation announces extension of JJIPO @ QUT in collaboration with Queensland State Government to further boost life-science innovation in Queensland
Read full storyJNJ Press releases
Johnson & Johnson Innovation Launches Champions of Science Storytelling Challenge – Latin America & Caribbean Edition
Read full storyJNJ Press releases
Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Winners of the Victorian QuickFire Challenge in Collaboration with Victorian Government
Read full storyJNJ Press releases
Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI
Read full storyJNJ Press releases
EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Memorandum of Understanding with Kyoto University to Collaborate in Identifying and Accelerating the Development of Innovative Healthcare Solutions
Read full storyJNJ Press releases